| Literature DB >> 30518152 |
Souaibou Yaouba1, Arto Valkonen2, Paolo Coghi3, Jiaying Gao4, Eric M Guantai5, Solomon Derese6, Vincent K W Wong7, Máté Erdélyi8,9,10, Abiy Yenesew11.
Abstract
A phytochemical investigation of the roots of Aspilia plurisetaled to the isolation of ent-kaurane-type diterpenoids and additional phytochemicals (1⁻23). The structures of the isolated compounds were elucidated based on Nuclear Magnetic Resonance (NMR) spectroscopic and mass spectrometric analyses. The absolute configurations of seven of the ent-kaurane-type diterpenoids (3⁻6, 6b, 7 and 8) were determined by single crystal X-ray diffraction studies. Eleven of the compounds were also isolated from the roots and the aerial parts of Aspilia mossambicensis. The literature NMR assignments for compounds 1 and 5 were revised. In a cytotoxicity assay, 12α-methoxy-ent-kaur-9(11),16-dien-19-oic acid (1) (IC50 = 27.3 ± 1.9 µM) and 9β-hydroxy-15α-angeloyloxy-ent-kaur-16-en-19-oic acid (3) (IC50 = 24.7 ± 2.8 µM) were the most cytotoxic against the hepatocellular carcinoma (Hep-G2) cell line, while 15α-angeloyloxy-16β,17-epoxy-ent-kauran-19-oic acid (5) (IC50 = 30.7 ± 1.7 µM) was the most cytotoxic against adenocarcinomic human alveolar basal epithelial (A549) cells.Entities:
Keywords: Aspilia mossambicensis; Aspilia pluriseta; Asteraceae; X-ray crystal structure; cytotoxicity; ent-kaurane diterpenoid
Mesh:
Substances:
Year: 2018 PMID: 30518152 PMCID: PMC6321058 DOI: 10.3390/molecules23123199
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The 1H (800 MHz) and 13C-NMR (200 MHz) data for compound 1 acquired in CDCl3.
| Position | δC Lit. [ | δC | HMBC (2 | |
|---|---|---|---|---|
| 1 | 38.17 | 40.6 | 1.14 | C-2, C-3, C-10, C-20 |
| 1.90 | C-2, C-3, C-10, C-20 | |||
| 2 | 18.35 | 20.0 | 1.43 | C-1, C-3, C-4, C-5, C-10 |
| 1.79 | C-1, C-4, C-5 | |||
| 3 | 29.03 | 38.1 | 0.93 | C-1, C-2, C-4, C-18, C-19 |
| 2.08 | C-1, C-4, C-5, C-7 | |||
| 4 | 43.43 | 44.6 | ||
| 5 | 43.81 | 46.1 | 1.56 | C-4, C-7, C-9, C-10, C-18, C-19, C-20 |
| 6 | 20.07 | 18.3 | 1.82 | C-3, C-4, C-5, C-7, C-10 |
| 2.43 | C-4, C-5, C-8 | |||
| 7 | 40.60 | 28.9 | 1.42 | C-5, C-6, C-8, C-9, C-15 |
| 1.95 | C-6, C-8, C-9, C-14, C-15 | |||
| 8 | 44.66 | 43.4 | ||
| 9 | 160.28 | 160.2 | ||
| 10 | 38.94 | 38.9 | ||
| 11 | 115.42 | 115.3 | 5.30 | C-8, C-9, C-10, C-12, C-13, C-15, C-20 |
| 12 | 81.79 | 81.7 | 3.38 | C-9, C-11, C-13, C-16, C-20, OCH3-12 |
| 13 | 46.17 | 43.7 | 2.89 | C-10, C-11, C-12, C-15, C-16 |
| 14 | 40.60 | 40.5 | 1.31 | C-7, C-8, C-9, C-12, C-13, C-15 |
| 1.58 | C-9, C-12, C-13, C-15, C-16 | |||
| 15 | 47.17 | 47.1 | 2.08 | C-7, C-8, C-9, C-16, C-17 |
| 2.35 | C-7, C-9, C-13, C-14, C-16, C-17 | |||
| 16 | 153.00 | 152.9 | ||
| 17 | 108.12 | 108.1 | 4.84 | C-12, C-13, C-15, C-16 |
| 4.94 | C-12, C-13, C-15, C-16 | |||
| 18 | 28.22 | 28.2 | 1.17 | C-3, C-4, C-5, C-8, C-19 |
| 19 | 182.98 | 183.2 | ||
| 20 | 23.41 | 23.4 | 1.01 | C-1, C-5, C-9, C-10 |
| OCH3-12 | 56.53 | 56.5 | 3.34 | C-12 |
* CDCl3 at 100 MHz [13].
Figure 1Structures of compounds 1–8.
Figure 2Some of the key NOE correlations observed for compound 1. The NOESY (Nuclear Overhauser Effect Spectroscopy) spectrum (800 MHz, CDCl3, 25 °C, 700 ms mixing time) is shown in the Supplementary Materials.
Figure 3Structures of compounds 9–23.
Figure 4Crystal structure representations of compounds 3–8. The structures were deposited with the following CCDC (Cambridge Crystallographic Data Centre) codes: 3 (1868318), 4 (1868319), 5 (1868321), 6 (1868320), 6b (1868324), 7 (1868323), and 8 (1868322).
The literature reported NMR data for 5, 5a, and 5b and the 1H (800 MHz) and 13C-NMR (200 MHz) data for compound 5 acquired in CDCl3.
| Position | 5 [ | 5a [ | 5b [ | 5 | 5 |
|---|---|---|---|---|---|
| δC | δC | δC | δC | ||
| 1 | 41.2 | 40.6 | 40.6 | 40.6 | 0.80 |
| 1.86* | |||||
| 2 | 28.9 | 19.8 | 19.0 | 19.7 | 1.55 |
| 1.75 | |||||
| 3 | 37.7 | 36.7 | 36.4 | 37.6 | 0.96 |
| 2.11 | |||||
| 4 | 43.6 | 46.9 | 47.8 | 43.5 | |
| 5 | 56.7 | 20.3 | 56.6 | 56.5 | 1.16 |
| 6 | 19.0 | 41.2 | 20.3 | 20.8 | 1.76 |
| 1.86* | |||||
| 7 | 35.4 | 47.8 | 41.2 | 35.3 | 1.25 |
| 1.79 | |||||
| 8 | 47.9 | 52.9 | 43.6 | 47.8 | |
| 9 | 52.9 | 43.6 | 53.0 | 52.8 | 1.28 |
| 10 | 39.8 | 56.6 | 39.8 | 39.7 | |
| 11 | 19.8 | 20.8 | 19.8 | 18.9 | 1.40 |
| 1.81 | |||||
| 12 | 20.8 | 28.9 | 28.9 | 28.8 | 1.50 |
| 13 | 41.2 | 36.4 | 35.1 | 41.1 | 1.82 |
| 14 | 36.5 | 37.7 | 37.7 | 36.4 | 1.68 |
| 1.97 | |||||
| 15 | 81.9 | 81.2 | 81.2 | 81.9 | 4.73 |
| 16 | 66.3 | 66.4 | 66.4 | 66.3 | |
| 17 | 49.6 | 49.6 | 49.6 | 49.6 | 2.78 |
| 3.09 | |||||
| 18 | 28.8 | 28.9 | 28.9 | 28.7 | 1.28 |
| 19 | 182.3 | 182.6 | 182.6 | 182.7 | |
| 20 | 15.7 | 15.8 | 16.0 | 15.9 | 1.03 |
| 1’ | 167.9 | 166.5 | 166.5 | 167.8 | |
| 2’ | 128.1 | 129.0 | 115.9 | 128.0 | |
| 3’ | 137.3 | 137.1 | 156.8 | 137.3 | 5.96 |
| 4’ | 15.9 | 27.4 | 20.8 | 15.7 | 1.96 |
| 5’ | 20.6 | 20.8 | 27.4 | 20.6 |
|
Cytotoxicity (IC50, μM) of compounds isolated from Aspilia species against various cell lines.
| Compound | Normal Cell Lines | Cancer Cell Lines | ||
|---|---|---|---|---|
| BEAS-2B | LO2 | A549 | Hep-G2 | |
|
| >100 | >100 | >100 | 27.3 ± 1.9 |
|
| >100 | >100 | >100 | >100 |
|
| 89.9 ± 2.0 | 57.2 ± 1.2 | >100 | 24.7 ± 2.8 |
|
| >100 | >100 | >100 | >100 |
|
| >100 | >100 | 30.7 ± 1.7 | >100 |
|
| >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 |
|
| >100 | 75.3 ± 2.8 | >100 | >100 |
|
| >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 |
|
| >100 | >100 | >100 | >100 |
|
| 38.6 ± 2.5 | 30.0 ± 1.7 | 80.5 ± 1.8 | 81.3 ± 0.3 |
| Paclitaxel | <0.1 | <0.1 | 0.0033 | 0.19 |